THE EFFECTS OF MEDIA EXPOSURE IN DIRECT- TO CONSUMER ADVERTISING OF PRESCRIPTION DRUGS, PATIENT...
-
Upload
curtis-melton -
Category
Documents
-
view
214 -
download
0
Transcript of THE EFFECTS OF MEDIA EXPOSURE IN DIRECT- TO CONSUMER ADVERTISING OF PRESCRIPTION DRUGS, PATIENT...
THE EFFECTS OF MEDIA EXPOSURE IN DIRECT-TO CONSUMER ADVERTISING OF
PRESCRIPTION DRUGS, PATIENT DEMAND, AND PATIENT SATISFACTION
140th Annual American Public Health Association (APHA) Conference
San Francisco, California
October 31,2012
Marvin Rock, Mian B. Hossain1, Andrea Kidd-Taylor1, H. Eduardo Velasco2
1 School of Community of Health and Policy, Morgan State University2 College of Osteopathic Medicine, Touro University
Presentation Outline 2
Rationale of the study Direct-to Consumer Advertising Definition Research Question & Hypotheses Conceptual Model & Adapted Model Data Source Univariate, Bivariate, Multivariate Models Analytical Model Conclusions
Rationale for the Study
3
Why Prescription Drugs? Cost (fastest rising health care expense) Leading to an increase in new medicines being
approved and marketed Consumer Demand is growing for new medications Intensification of prescription drug marketing has lead
to DTCA
Congressional Budget Office, 2006
Direct to Consumer Advertising (DTCA)-- Defined
DTCA : the promotion of prescription drugs directly to the consumer
through the following methods:
Sources of DTCA:
Newspaper
Magazine Print
Television or radio Broadcast
Internet marketing (Social Marketing i.e. Facebook, Twitter, and Blogs )
Online
Family & Friends Other
Healthcare providers
Consumer for Media and Democracy, 2007
Research Question and Research Hypotheses5
RQ1: What are the health determinants of patient demand?
Relationship between differing levels of media exposure of DTCA prescription drugs
H1: Do differing levels of media exposure (hi, med, lo) affect patient demand
H2: Does health insurance status moderate the effects of media exposure and patient demand
H3: Are patients with higher levels of media exposure more likely to have patient satisfaction adjusting for all other variables
Bero’s Conceptual Model: (2001)
1. DTC Advertising• Exposure (Ad
Expenditures)• Content• Accuracy
2. Consumer Attitudes:• Consumer Assess. of DTC
Ads• Profit Motivated Ads vs.
Public Service Announcements
• Promotion vs. Education• Medicalization of Everyday
Problems
3. Patient Demand
5. Patient-Physician Relationship
• Satisfaction• Trust• Visit Efficiency
4. Physician Attitudes
6. Prescribing(Physician Actions)• Quality of Prescribing• Quantity of Generic Drug Prescribe• Quantity of Brand Name Drug
Prescribed(Physician Group/HMO Actions)• Formulary Compliance• Economic Viability of the Group /HMO
7. Adherence with Drug Therapy
9. Health Care Costs• Drug Costs to Consumers &
Health Plans• Physician Visits• Diagnostic Tests• Hospitalization
8.Patients’ Health Outcomes
• Perceived Health Status
• Objective Measures of Health Status
10. Pharmaceutical Industry• Market Share• Profit Level
Bero, 2001
Adapted Conceptual Model: (Rock)
DTC Advertising• Media Exposure
Patient Demand
Patients’ Health Outcomes• Adverse Drug Events• Patient Satisfaction• Health Related QoL
Rock, 2011
“Public Health Impact of Direct to Consumer Advertising of Prescription Drugs”(ICPSR 3687)
8
Cross-sectional study design Secondary data taken from 2001/2002 Public Health Impact
of Direct-to-Consumer Advertising of Prescription Drugs (n=3000)
Twenty minute telephone interview, with a nationally representative sample (telephone households in Continental United States) Sample size (3000), 18 years of age and older Stratified sampling process Households selected computerized by Random Digit Dialing (RDD)
Genesys Sampling System Based on # households in the exchange Proper representations of households in different regions Central city, suburban, rural
Weissman et al., 2003
Study Covariates9Variables Type
Health status Categorical
Gender Dichotomous
Age Categorical
Education Categorical
Health insurance status Dichotomous
Marital status Categorical
Income Categorical
Employment status Dichotomous
Geographic region Categorical
Health Related Quality of Life Dichotomous
Race/ethnicity Categorical
Adverse Drug Events Dichotomous
10
Variable Proportion Sample size
(n)
Socio-demographic variables
Media exposure (n=2,957)
Low media exposure 0.35 992
Medium media exposure 0.34 989
High media exposure 0.47 976
Overall Exposure to health information (n=2,879)
Television or radio 0.15 412
Internet 0.13 359
Mass media & print media 0.14 412
Print media 0.17 522
Family & Friends 0.16 480
Health provider 0.24 694
Weighted socio-demographic and Health characteristics of the study population
11
Variable Proportion Sample size (n)
Patient Demand
Advertisement prompted to talk to Dr. (n=2,592)
Yes 0.31 801
No 0.69 1,791
Patient Satisfaction
Overall do you feel better after taking prescribed
drug (n=650)
Better 0.81 520
Worse 0.19 130
Weighted distributions of patient demand and patient satisfaction, two outcome variables for the study
Bivariate Association Between Media Exposure and Other Covariates with Patient Demand
Independent Variables Patient Demand
Media Exposure S
Geographic Region NS
Income NS
Health insurance NS
Gender S
Race/Ethnicity NS
Marital Status NS
Employment Status NS
Age NS
Education NS
Health Status S
Geographic Location S
S: Statistically significant with at least 95% confidence.
NS: Not statistically significant.
Independent Variables Patient Satisfaction
Media Exposure NS
Geographic Region NS
Income S
Health Insurance NS
Gender NS
Race/Ethnicity S
Marital Status NS
Employment Status NS
Age NS
Education NS
Health Status NS
Geographic location NS
HRQL S
ADE S
Bivariate Association Between Media Exposure and Other Covariates with Patient Satisfaction
S: Statistically significant with at least 95% confidence.
NS: Not statistically significant.
Analytical Models
14
Logistic regression- Patient Demand (yes/no) and Patient Satisfaction (better/worse)
Model 1-3: Media exposure (TV, radio, print, and Internet) Patient demand Socio-demographic variables Health status
Model 4: Model 1+interaction between health insurance status Model 5-7: Media exposure & patient satisfaction controlling for SD,
HS, Adverse Drug Events, and Health Relate Quality of Life Model 8: Model 5+interaction between health insurance status Odds ratios
Less likely to demand & less satisfied OR<1 PD(no)/ PS (worse) More likely to demand & more satisfied OR>1 PD(yes)/ PS (better)
15
CovariatesModel 1 Model 2 Model 3
OR 95% CI OR 95% CI OR 95% CI
Media exposure
Low media exposure (RC) 1.00 - 1.00 - 1.00 -
Medium media exposure 1.53*** 1.11, 3.48 1.54*** 20,1.97 1.51** 1.16, 1.97
High media exposure 2.32*** 95,2.78 2.33*** 1.83, 2.96 2.30*** 1.77, 2.98
Health Insurance
Insured (RC) - - 1.00 - 1.00 -
Uninsured - - 0.86 0.63, 1.18 0.79 0.56, 1.13
Logistic regression models estimates for the relationship between patient’s levels of media exposure and patient demand
Significance: * p<0.05; ** p<0.01; *** p<0.001
16
Covariates Model 4
OR 95% CI
Media exposure
Low media exposure (RC) 1.00 -
Medium Media exposure 2.14 0.93. 4.90
High media exposure 2.71** 1.22, 5.99
Health Insurance
Insured (RC) 1.00 -
Uninsured 0.64 0.33, 1.26
Media exposure x Health Insurance status
int_media_exp_low_new_healthins2 - -
int_media_exp_low_new_healthins1(RC) 1.00 -
Logistic regression models estimates for the relationship between patient’s levels of media exposure, patient demand ,
and the interaction term
17
Covariates Model 5 Model 6 Model 7
OR 95% CI OR 95% CI OR 95% CI
Media exposure
Low media exposure (RC) 1.00 - 1.00 - 1.00 -
Medium media exposure 1.96* 1.11, 3.48 1.98** 1.12, 3.50 2.14* 1.08, 4.22
High media exposure 1.63 0.95, 2.78 1.63 0.95,2.79 1.83 0.94,3.60
Experiencing any side effects from taking rx
drug
Yes (RC) - - - - 1.00 -
No - - - - 3.25*** 1.90, 5.56
Prescribed drug had effect on your ability
Decreased ability (RC) - - - - 1.00 -
Increased ability - - - - 5.80*** 2.69,12.50
Intercept 1.03 0.967 0.077
Sample Size 643 643 583
Logistic regression estimates for the relationship between media exposure and patient’s satisfaction controlling for all other variables
Significance: * p<0.05; ** p<0.01; *** p<0.001
Conclusions
Patients with higher levels of exposure to media (medium and high exposure) are significantly more likely to have patient demand
The interaction between patient demand and health insurance status was not a significant factor or moderator in the media exposure patient demand relationship
Patients with medium level of media exposure are significantly more likely to have patient satisfaction, adjusting for adverse drug events and health related quality of life, socio-demographic variables, and health status
Future Implications 19
Further need to conduct research on DTCA of prescription drugs & patient health outcomes
Readdressing current policies on this form of health communication
Risk/benefit drug information available to patients Post approval risk/benefit analysis Quicker evaluation of drug ads that violate quality of life
and economic claims Reevaluation of the current regulations on DTCA
Acknowledgements
Dr. Mian Hossain Dr. Andrea Kidd-Taylor Dr. Neil Alperstein Dr. Lisa Bero Dr. Mary Carter Dr. Barbara Mintzes Dr. Joel Weissman Dr. Lester Spence
Dr. Eduardo Velasco Dr. Timothy Akers Dr. Jonathan VanGeest Dr. Robert Jagers University of Michigan
Inter-university Consortium for Political and Social Research
20
Thank you Thank You
Marvin A. Rock, Dr.P.H., M.P.H.
Health Outcomes Scientist/ Epidemiologist
Contact Information 21
Questions?22